Dermata Therapeutics, Inc. (DRMA) Social Stream



Dermata Therapeutics, Inc. (DRMA): $0.52

0.01 (+1.96%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DRMA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 458

in industry

Dermata Therapeutics Inc (DRMA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Dermata Therapeutics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-17 2 $14 $9 $11.5 $1.28 798.44%
2022-03-30 2 $14 $4 $9 $1.28 603.12%

DRMA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, Dermata Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 195.46% of them.
  • To contextualize these metrics, consider that out of all US stocks, Dermata Therapeutics Inc's number of analysts covering the stock is higher than 9.42% of them.
  • In the context of all US stocks, Dermata Therapeutics Inc's average analyst price target is higher than 18.2% of them.
  • In terms of how Dermata Therapeutics Inc fares relative to stocks in the nano market cap category, note that its variance in analysts' estimates is lower than -79.41% of that group.

Stocks similar to Dermata Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BNTC, VECT, and SMFL.

Is DRMA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4924 seconds.